Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C

Journal of Medical Virology

Volumn 49, Issue 3, 1996, Pages 242-247

  González Peralta, Regino P ^a   Qian, Keping ^a   She, Jan Y ^a   Davis, Gary L ^a   Ohno, Tomoyoshi ^b   Mizokami, Masashi ^b   Lau, Johnson Y N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

HCV; heterogeneity; interferon; quasispecies; viremia

Indexed keywords

ALPHA INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; RELAPSE; SINGLE STRAND CONFORMATION POLYMORPHISM; SPECIES DIFFERENCE; VIREMIA;

ADULT; AGED; CHRONIC DISEASE; FEMALE; GENETIC HETEROGENEITY; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 0029785058     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199607)49:3<242::AID-JMV14>3.0.CO;2-E     Document Type: Article

References (27)

1. Collins ML, Zayati C, Detmer JJ, Daly B, Kolberg JA, Cha TA, Irvine BD, Tucker J, Urdea MS (1995): Preparation and characterization of RNA standards for use in branched DNA hybridization assays. Annals of Biochemistry 226:120-129.
2. Davis GL, Lau JYN, Urdea MS, Neuwald P, Wilber JC, Lindsay K, Perrillo RP, Albrecht J (1994): Quantitative detection of hepatitis C virus RNA by solid phase branched DNA amplification method: definition and optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19: 1337-1341.
3. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C (1995): Comparison of fulllength sequence of interferon-sensitive and resistant hepatitis C virus: Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigation 96:224-230.
4. Evans DMA, Dunn G, Minor PD, Schild C, Cann AJ, Stanway G, Almond JW, Currey K, Malad JV (1985): Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 polio vaccine genome. Nature 314:548-550.
5. Hayashi K. PCR-SSCP (1992): A method for detection of mutations. GATA 9:73-79.
6. Hayashi J, Kishihara Y, Yoshimura E, Tani Y, Kouzaburo Y, Ikematsu H, Ishiko H, Kashiwagi S (1995): Relationship of genotype to level of hepatitis C viremia determined by competitive polymerase chain reaction. Journal of Infection 30:235-239.
7. Higashi Y, Kakumu S, Yoshioka K, Wakita T, Mizokami M, Ohba K, Ito Y, Ishikawa T, Takayanagi M, Nagai Y (1993): Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197:659-668.
8. Kanazawa Y, Hayashi N, Mita E, Li T, Hagiwara H, Kasahara A, Fusamoto H, Kamada T (1994): Influence of viral quaisispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 20:1121-1130.
9. Kato N, Ootsuyama Y, Ohkoshi S, Nakazawa T, Sekiya H, Hijikata M, Shimotohno K (1992): Characterization of the hypervariable regions in the putative envelope protein of hepatitis C virus. Biochemical Biophysical Research Communication 189:119-127.
10. Kew OM, Nottay BK (1984): Evolution of the oral polio vaccine strains in humans occurs by both mutations and intramolecular recombination. In Chanock RM, Lerner RA (eds): "Modern Approaches to Vaccines." Cold Spring Harbor: Cold Spring Harbor Laboratory, pp 357-367.
11. Kumar U, Monjardino J, Thomas JC (1994): Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology 106:1072-1075.
12. Kwok S, Higuchi R (1989): Avoiding false positives with PCR. Nature 339:237-238.
13. Lau JYN, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Nuewald PD, Wilber JC (1993): Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504.
14. Lau JYN, Simmonds P, Urdea MS (1995a): Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 346: 425-426.
15. Lau JYN, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, Lindsay KL, Gish RG, Qian KP, Kohara M, Simmonds P, Urdea MS (1995b): Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. Journal of Infectious Diseases 171:281-289.
16. Lau JYN, Davis GL, Prescott LE, Maertens G, Lindsay KL, Qian K, Mizokami M, Simmonds P, and the Hepatitis Interventional Group (12996): Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Annals of Internal Medicine 124:868-876.
17. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J (1992): Hepatitis C virus circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. Virology 66:3225-3229.
18. Moribe T, Hayashi N, Kanasawa Y, Mita E, Fusamoto H, Negi M, Kaneshige T, Manda M, Igimi H, Kamada T, Uchida K (1995): Hepatitis C viral complexicity detected by single strand conformational polymorphism and response to interferon therapy. Gastroenterology 108:789-795.
19. Okada SI, Akahane Y, Suzuki H, Okamoto H, Mishiro S (1992): The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619-624.
20. Okamoto H, Okada S, Sugiyama Y, Kurai K, Iioka H, Michida A, Miyakawa Y, Mayumi M (1991): Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates from conserved and divergent regions. Journal of General Virology 72:2697-2704.
21. Parry N, Fox G, Rowland D, Brown F, Fry E, Acharaya D, Logan D, Stuart D (1990): Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347:569-572.
22. Remington KM, Chesebro B, Wehrly K, Pederson NC, North TW (1991): Mutants of feline immunodeficiency virus resistant to 3′-azido-3′deoxythymidine. Journal of Virology 65:308-312.
23. Simmonds P, Alberti A, Bonino F, Bradley DW, Brechot C, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers TM, Date T, Esteban T, Fay O, Han J, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Lau JYN, Lelie N, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesnik HW, Rice C, Roggendorf M, Shimotohno K, Stuyer L, Trepo C, Weiner A, Yap PL, Urdea MS (1994): A proposed system for nomenclature of genotypes for hepatitis C virus. Hepatology 19:1321-1324.
24. Smith DB, Davidson F, Yap PL, Brown H, Kolberg J, Detmer J, Urdea M, Simmonds P, the International HCV Collaborative Study Group (1996): Levels of hepatitis C virus blood donors infected with different virus genotypes. Journal of Infectious Diseases, 173:727-730.
25. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonnino F, Saracco G, Choo QL, Houghton M, Han JH (1991): Variable and hypervariable domains are found in the regions of HCV corresponding to the flavirus envelope and NS1 proteins and the pestivirus envelope glycoprotein. Virology 180:842-848.
26. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M (1992): Evidence for immune selection of hepatitis C virus putative envelope glycoprotein variants: potential role in chronic HCV infection. Proceedings of the National Academy of Science USA 89:368-372.
27. Yamagushi K, Tanaka E, Higashi K, Kiyosawa K, Matsumoto A, Furuta S, Hagesawa A, Tanaka S, Kohara M (1994): Adaptation of hepatitis C virus for persistent infection in patients with acute hepatitis. Hepatology 106:1344-1348.